Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04377932
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Who this might be right for
Liver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more
Baylor College of Medicine 14
Testing effectiveness (Phase 2)Ended earlyNCT00072280
What this trial is testing

Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 7
Early research (Phase 1)Looking for participantsNCT06441331
What this trial is testing

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Who this might be right for
Somatostatin Receptor PositiveNETsLymphoma+5 more
ITM Solucin GmbH 20
Testing effectiveness (Phase 2)Study completedNCT01294670
What this trial is testing

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Who this might be right for
Solid TumorsRelapsed/Refractory Sarcomas
Memorial Sloan Kettering Cancer Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT05634369
What this trial is testing

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

Who this might be right for
Pediatric Sarcoma, RefractoryPediatric Sarcoma, Relapsed
Nationwide Children's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00025441
What this trial is testing

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
Societe Internationale d'Oncologie Pediatrique
Post-approval studies (Phase 4)Study completedNCT04854018
What this trial is testing

Indo-cyanine Green (ICG) in Paediatric Oncology MIS

Who this might be right for
Pediatric Renal TumorMetastatic OsteosarcomaMetastatic Ewing Sarcoma+3 more
Birmingham Women's and Children's NHS Foundation Trust 20
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Looking for participantsNCT05985161
What this trial is testing

Selinexor in People With Wilms Tumors and Other Solid Tumors

Who this might be right for
Wilms TumorRhabdoid TumorMalignant Peripheral Nerve Sheath Tumors+4 more
Memorial Sloan Kettering Cancer Center 45
Not applicableStudy completedNCT04956198
What this trial is testing

Drug Sensitivity and Mutation Profiling

Who this might be right for
Ewing SarcomaOsteosarcomaRhabdomyosarcoma+4 more
Florida International University 14
Early research (Phase 1)Looking for participantsNCT03900793
What this trial is testing

Losartan + Sunitinib in Treatment of Osteosarcoma

Who this might be right for
Osteosarcoma
University of Colorado, Denver 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT02574728
What this trial is testing

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Who this might be right for
Cancer
Emory University 46
Early research (Phase 1)Not Yet RecruitingNCT07773454
What this trial is testing

Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
CancerPediatric Cancer
Exelixis 18
Testing effectiveness (Phase 2)Study completedNCT04216953
What this trial is testing

MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma,Soft Tissue
Centre Leon Berard 229
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT06848582
What this trial is testing

Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study

Who this might be right for
Soft Tissue Sarcoma (STS)
Sun Yat-sen University 40
Not applicableActive Not RecruitingNCT01117168
What this trial is testing

Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group

Who this might be right for
Pediatric CancerLeukemiaSarcoma+1 more
Children's Oncology Group 57,816
Testing effectiveness (Phase 2)Study completedNCT00357500
What this trial is testing

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Who this might be right for
Central Nervous System Tumor, PediatricLeukemiaLymphoma+3 more
Dana-Farber Cancer Institute 101
Next Page